In order to determine the parameters that govern the activity of a ribozyme
in vivo, we made a systematic analysis of chimeric tRNA(Val) ribozymes by
measuring their cleavage activities in vitro as well as the steady-state le
vels of transcripts, the half-lives of transcribed tRNA(Val) ribozymes, and
their activities in both HeLa and H9 cells. These analyses were conducted
by the use of transient expression systems in HeLa cells and stable transfo
rmants that express ribozymes. Localization of transcripts appeared to be d
etermined by the higher-order structure of each transcribed tRNA(Val) riboz
yme. Since colocalization of the ribozyme,vith its target RNA is important
for strong activity of the ribozyme in vivo, the best system for tRNA-based
expression seems to be one in which the structure of the transcript is dif
ferent from that of the natural tRNA precursor so that processing of the tR
NA(Val) ribozyme can be avoided. At the same time, the structure of the tra
nscript must be similar enough to allow recognition, probably by an export
receptor, so that the transcript can be exported to the cytoplasm to ensure
colocalization with its target. In the case of several tRNA(Val) ribozymes
that we constructed, inspection of computer-predicted secondary structures
enabled us to control the export of transcripts. We found that only a ribo
zyme that was transcribed at a high level and that had a sufficiently long
half-life, within cells, had significant activity when used to withstand a
challenge by human immunodeficiency virus type 1.